H34.813
Central retinal vein occlusion, bilateral
Clinical Classification Guidelines
Medical Intelligence & Overview
Central Retinal Vein Occlusion (CRVO) is a serious eye condition where the main vein carrying blood away from the retina becomes blocked. When this occurs in both eyes simultaneously, it is classified as bilateral CRVO. This condition can lead to significant visual impairment if not diagnosed and managed promptly. Understanding the causes, symptoms, and potential treatments can help individuals recognize early signs and seek appropriate care.
Causes & Symptoms
Clinical Causes: Blood clot formation within the central retinal vein Atherosclerosis or hardening of the arteries High blood pressure (hypertension) Diabetes mellitus Glaucoma or increased intraocular pressure Blood disorders such as blood clotting abnormalities or anemia Inflammatory conditions affecting blood vessels Age-related changes in blood vessels Smoking and other lifestyle factors
Key Symptoms: Sudden, painless loss of vision in one or both eyes Blurry or distorted vision Visual blood spots or floaters A sudden decrease in visual acuity In some cases, no noticeable symptoms until extensive damage occurs
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive eye examination, including visual acuity testing and fundoscopy to inspect the retina. Imaging studies such as optical coherence tomography (OCT) and fluorescein angiography help assess the extent of the blockage and determine the severity. A thorough medical history and evaluation for underlying systemic conditions are also essential components of diagnosis.
Treatment Protocols: Treatment strategies focus on managing the underlying causes and preventing further vision loss. Common approaches include: - Intravitreal injections of anti-VEGF agents to reduce macular swelling and improve vision - Corticosteroid injections to decrease inflammation and edema - Laser therapy to treat abnormal blood vessels - Controlling systemic risk factors such as hypertension, diabetes, and cholesterol levels - Regular monitoring to assess disease progression and treatment response It is important for individuals with bilateral CRVO to work closely with both their eye specialist and primary healthcare provider to optimize eye health and address systemic health issues.
Clinical Advice & FAQs
Billing Guidance
Is H34.813 a billable ICD-10 code?
Yes, H34.813 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report H34.813?
Clinical documentation must specify the nature of Central retinal vein occlusion, bilateral and any associated comorbidities for accurate reporting.
Cite this Clinical Reference